These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27956344)

  • 1. Design, synthesis and cytotoxic activities of scopoletin-isoxazole and scopoletin-pyrazole hybrids.
    Shi W; Hu J; Bao N; Li D; Chen L; Sun J
    Bioorg Med Chem Lett; 2017 Jan; 27(2):147-151. PubMed ID: 27956344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and cytotoxic evaluation of novel scopoletin derivatives.
    Shi W; Zhang J; Bao N; Guan F; Chen L; Sun J
    Chem Biol Drug Des; 2018 Feb; 91(2):641-646. PubMed ID: 29052945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro antitumor activity of novel scopoletin derivatives.
    Liu W; Hua J; Zhou J; Zhang H; Zhu H; Cheng Y; Gust R
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5008-12. PubMed ID: 22765897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, in vitro and in vivo antitumor activity of scopoletin-cinnamic acid hybrids.
    Li L; Zhao P; Hu J; Liu J; Liu Y; Wang Z; Xia Y; Dai Y; Chen L
    Eur J Med Chem; 2015 Mar; 93():300-7. PubMed ID: 25703298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and efficient synthesis of pyrazoline and isoxazole bridged indole C-glycoside hybrids as potential anticancer agents.
    Kumari P; Mishra VS; Narayana C; Khanna A; Chakrabarty A; Sagar R
    Sci Rep; 2020 Apr; 10(1):6660. PubMed ID: 32313038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Scopoletin Derivatives Kill Cancer Cells by Inducing Mitochondrial Depolarization and Apoptosis.
    Shi Z; Chen L; Sun J
    Anticancer Agents Med Chem; 2021; 21(14):1774-1782. PubMed ID: 33292145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of (Z)-(arylamino)-pyrazolyl/isoxazolyl-2-propenones as tubulin targeting anticancer agents and apoptotic inducers.
    Kamal A; Reddy VS; Shaik AB; Kumar GB; Vishnuvardhan MV; Polepalli S; Jain N
    Org Biomol Chem; 2015 Mar; 13(11):3416-31. PubMed ID: 25661328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of novel marine bromopyrrole alkaloid-based hybrids as anticancer agents.
    Rane RA; Sahu NU; Gutte SD; Mahajan AA; Shah CP; Bangalore P
    Eur J Med Chem; 2013 May; 63():793-9. PubMed ID: 23584542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of pyrazole/isoxazole linked arylcinnamides as tubulin polymerization inhibitors and potential antiproliferative agents.
    Kamal A; Shaik AB; Rao BB; Khan I; Bharath Kumar G; Jain N
    Org Biomol Chem; 2015 Oct; 13(40):10162-78. PubMed ID: 26303171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial, Antioxidant, and Anticancer Activities of Some Novel Isoxazole Ring Containing Chalcone and Dihydropyrazole Derivatives.
    Shaik A; Bhandare RR; Palleapati K; Nissankararao S; Kancharlapalli V; Shaik S
    Molecules; 2020 Feb; 25(5):. PubMed ID: 32110945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative novel isoxazoles: modeling, virtual screening, synthesis, and bioactivity evaluation.
    Tzanetou E; Liekens S; Kasiotis KM; Melagraki G; Afantitis A; Fokialakis N; Haroutounian SA
    Eur J Med Chem; 2014 Jun; 81():139-49. PubMed ID: 24836066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vitro cytotoxic activity evaluation of novel heterocycle bridged carbothioamide type isosteviol derivatives as antitumor agents.
    Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1343-6. PubMed ID: 23347685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of electron-rich curcumin analogues.
    Amolins MW; Peterson LB; Blagg BS
    Bioorg Med Chem; 2009 Jan; 17(1):360-7. PubMed ID: 19019687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and stereoselective synthesis of novel isosteviol-fused pyrazolines and pyrazoles as potential anticancer agents.
    Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM
    Eur J Med Chem; 2013 Jul; 65():70-82. PubMed ID: 23693151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and anti-acetylcholinesterase activity of scopoletin derivatives.
    Khunnawutmanotham N; Chimnoi N; Saparpakorn P; Techasakul S
    Bioorg Chem; 2016 Apr; 65():137-45. PubMed ID: 26943478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, antimicrobial and anti-cancer activities of some new N-ethyl, N-benzyl and N-benzoyl-3-indolyl heterocycles.
    El-Sawy ER; Mandour AH; Mahmoud K; Islam IE; Abo-Salem HM
    Acta Pharm; 2012 Jun; 62(2):157-79. PubMed ID: 22750815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of pyrazole-pyrazoline hybrids as cancer-associated selective COX-2 inhibitors.
    Akhtar W; Marella A; Alam MM; Khan MF; Akhtar M; Anwer T; Khan F; Naematullah M; Azam F; Rizvi MA; Shaquiquzzaman M
    Arch Pharm (Weinheim); 2021 Jan; 354(1):e2000116. PubMed ID: 33015829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
    Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
    BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and antitumor activity of Novel Sorafenib derivatives bearing pyrazole scaffold.
    Wang M; Xu S; Lei H; Wang C; Xiao Z; Jia S; Zhi J; Zheng P; Zhu W
    Bioorg Med Chem; 2017 Oct; 25(20):5754-5763. PubMed ID: 28927801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
    Bakr RB; Mehany ABM; Abdellatif KRA
    Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.